Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.4K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

229
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
229
Subviral Agents01:29

Subviral Agents

207
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
207
Retroviruses02:33

Retroviruses

12.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metabolite.

Antimicrobial agents and chemotherapy·2026
Same author

Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir.

Science advances·2026
Same author

1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases.

Viruses·2026
Same author

Template switching by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir.

bioRxiv : the preprint server for biology·2025
Same author

Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025.

Antiviral research·2025
Same author

Practical perspectives on addressing hepatotoxicity during clinical candidate selection.

Expert opinion on drug metabolism & toxicology·2025
Same journal

The peptidomimetic approach for the design of viral protease inhibitors.

The Enzymes·2025
Same journal

Computational approaches for designing viral protease inhibitors.

The Enzymes·2025
Same journal

Challenges for developing selective viral protease inhibitors as antiinfectives.

The Enzymes·2025
Same journal

Bacteriophage endolysins.

The Enzymes·2025
Same journal

Flaviviruses proteases.

The Enzymes·2025
Same journal

Coronaviruses papain-like proteases and their inhibitors.

The Enzymes·2025
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

HCV RdRp, sofosbuvir and beyond.

Joy Y Feng1, Adrian S Ray2

  • 1Gilead Sciences, Inc., Foster City, CA, United States.

The Enzymes
|October 26, 2021
PubMed
Summary
This summary is machine-generated.

Hepatitis C Virus (HCV) nonstructural protein 5B (NS5B) RNA-dependent RNA polymerase (RdRp) targeting advanced antiviral drug discovery. Sofosbuvir

Keywords:
AntiviralHCVNS5BNucleoside/tide inhibitorsRdRpRemdesivirSofosbuvir

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.3K

Related Experiment Videos

Last Updated: Oct 15, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.3K

Area of Science:

  • Virology
  • Biochemistry
  • Drug Discovery

Background:

  • Hepatitis C Virus (HCV) nonstructural protein 5B (NS5B) is an RNA-dependent RNA polymerase (RdRp) crucial for viral replication.
  • Developing biochemical assays for HCV RdRp was challenging due to protein solubility and template issues.

Purpose of the Study:

  • To understand the structure, function, and substrate specificity of HCV RdRp.
  • To explore nucleotide analogs as inhibitors of HCV RdRp.
  • To inform antiviral drug discovery for RNA viruses.

Main Methods:

  • Biochemical assay development for HCV RdRp.
  • Crystallography to determine the ternary structure of HCV RdRp with nucleotide analogs.
  • Investigating substrate specificity and resistance mutations.
  • Assessing off-target toxicity in host polymerases.

Main Results:

  • HCV RdRp supports rapid and processive transcription initiation in vitro.
  • Sofosbuvir's active triphosphate acts as a nonobligate chain terminator for viral RNA.
  • Crystal structure revealed interactions within the 2'-hydroxyl binding pocket and resistance mechanisms.
  • Sofosbuvir's metabolite showed low incorporation by host polymerases, minimizing off-target toxicity.

Conclusions:

  • Targeting HCV NS5B RdRp provides insights into viral polymerase inhibition.
  • Understanding substrate specificity led to effective antiviral agents like sofosbuvir.
  • Knowledge gained aids in developing antivirals for other RNA viruses, such as remdesivir for SARS-CoV-2.